National and international developments in cancer, health and policy. Produced in collaboration with the Press Association unless otherwise stated.
There are stark differences in how long people in different parts of England can expect to live a healthy life, according to a new report.
The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found.
A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.
Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.
The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.